This Conference, the first of its kind in Europe, will examine how nanotechnology could contribute to alternatives to animal testing and also to realisation of the "3Rs鈥�, whilst maintaining the necessary high levels of safety in the pharmaceutical, medical device, chemical, cosmetic and environmental industries.
At this event, leading international experts will
- review some of the most promising new, human cell-based in vitro models
- describe novel lab-on-a-chip and bioreactor systems for screening, and for toxicological and targeting studies
- examine how understanding of the behaviour of materials at the nanoscale can be used to improve biosensors and diagnostic systems
- consider new paradigms for applying alternatives incorporating nanotechnology
At this event, leading international experts will
- review some of the most promising new, human cell-based in vitro models
- describe novel lab-on-a-chip and bioreactor systems for screening, and for toxicological and targeting studies
- examine how understanding of the behaviour of materials at the nanoscale can be used to improve biosensors and diagnostic systems
- consider new paradigms for applying alternatives incorporating nanotechnology
